  The present industry update covers the period 1-31 March 2018. Sources of information included company press releases , regulatory and patent agencies notices and various news websites. A number of companies reported positive early-stage clinical trial results for therapeutic candidates enabled by different delivery strategies including Cerenis Therapeutics Inc. and Enteris. March also saw the announcement of some significant collaborations; Bluebird Bio and Celgene announced plans for a collaboration with a view to developing a novel CAR-T therapy , and Windtree Therapeutics Inc. and Eleison Pharmaceuticals Inc. agreed to form a partnership to facilitate the delivery of inhaled liquid cisplatin. InMed Pharmaceuticals and OncoSec Medical Inc. , companies engaged at preclinical evaluation of their delivery technologies , also announced publications this month on the development of their platforms.